Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Alternavita
WARNING LETTER
•Alternavita•May 19, 2020

Alternavita – FDA Warning Letter, May 19, 2020

Record Details

The FDA and FTC issued a Warning Letter to Alternavita.com after reviewing its website on May 8 and May 19, 2020. The firm, participating in the Amazon Associates program, promoted products like grapefruit seed extract, colostrum, and cod liver oil with claims implying they could mitigate, prevent, treat, diagnose, or cure COVID-19. These claims render the products unapproved new drugs under FD&C Act section 505(a) and misbranded drugs under section 502. The introduction of these products into interstate commerce is prohibited under sections 301(a) and (d), and any act leading to misbranding after interstate shipment is prohibited under section 301(k). The FTC also found it unlawful under 15 U.S.C. 41 et seq. to advertise disease treatment without competent scientific evidence, which is absent for these COVID-19 claims. Alternavita must immediately cease promoting these unapproved products. Within 48 hours, the firm must email both FDA (COVID-19-Task-Force-CDER@fda.hhs.gov) and FTC (rcleland@ftc.gov) detailing corrective actions, including steps to prevent recurrence and supporting documentation. Failure to comply may result in legal action, including seizure, injunction, placement on FDA's public warning list, and potential consumer restitution for FTC violations.

Company
Alternavita
Inspection date
May 19, 2020
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Donald D. Ashley (Director)
  • Richard A. Quaresima
View Company Profile

ID · f7425120-4ae7-4fb9-8217-8b032332e6b3

Violation Codes5
21.U.S.C. 355(a)21 U.S.C. 35221 U.S.C. 331(d)21 U.S.C. 331(k)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Alternavita
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.